RhyGaze AG
Basel, CH · 3 known investors
RhyGaze develops gene therapies using optogenetic proteins to restore sight in patients with vision loss caused by retinal photoreceptor dysfunction. The company combines optogenetic technology with gene therapy delivery methods to enable light detection in degenerative eye conditions.
BiotechDigital HealthMedical Devices
Founders & leadership
BR
Botond RoskaResearcher (M.D., Ph.D.)
BG
Bence GyörgyIOB Assistant Professor & Head of Clinical Translation
KH
Katherine HighCEO